Quest Diagnostics

DGX Health Care Market cap $27.9B as of Oct 29, 2026 16:00 ET S&P 500

Q3 FY26 Jul 1 – Sep 30, 2026 reported Oct 23, 2026

Revenue$3.10B +10% year over year

Gross profit$1.04B 34% margin

Operating profit$0.48B 15% margin

Net profit$0.31B 10% margin

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q3 FY26 (period ends Sep 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	3.10	100%	+10%
DIS business	2.98	96%
All other operating	0.07	2%
Other revenue	0.05	2%
Cost of revenue	−2.06	66%
Gross profit	1.04	34% margin	+0pp
SG&A	−0.52	17%	−1pp
Other	−0.04	1%	+0pp
Operating profit	0.48	15% margin	+2pp
Interest & other costs	−0.07
Tax	−0.10
Net profit	0.31	10% margin	+1pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	3.04	100%	+10%
Diagnostic information	2.98	98%	+10%
All other	0.07	2%	+5%
Cost of revenue	−2.02	66%
Gross profit	1.03	34% margin	+0pp
SG&A	−0.53	18%	+0pp
Other	−0.04	1%	+0pp
Operating profit	0.46	15% margin	−1pp
Interest & other costs	−0.05
Tax	−0.09
Net profit	0.32	11% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	2.90	100%	+9%
Diagnostic information	2.83	98%	+9%
All other	0.06	2%	+0%
Cost of revenue	−1.95	67%
Gross profit	0.94	33% margin	+0pp
SG&A	−0.50	18%	−1pp
Other	−0.04	1%	+0pp
Operating profit	0.40	14% margin	+1pp
Interest & other costs	−0.07
Tax	−0.07
Net profit	0.25	9% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	2.81	100%	+7%
Diagnostic information	2.74	98%	+7%
All other	0.06	2%	−2%
Cost of revenue	−1.90	68%
Gross profit	0.91	32% margin	+0pp
SG&A	−0.50	18%	+0pp
Other	−0.02	1%	+0pp
Operating profit	0.39	14% margin	+0pp
Interest & other costs	−0.06
Tax	−0.08
Net profit	0.25	9% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	2.82	100%	+13%
Diagnostic information	2.76	98%	+14%
All other	0.06	2%	+0%
Cost of revenue	−1.87	66%
Gross profit	0.95	34% margin	+1pp
SG&A	−0.50	18%	+0pp
Other	−0.06	2%	+0pp
Operating profit	0.39	14% margin
Interest & other costs	−0.06
Tax	−0.08
Net profit	0.25	9% margin	+0pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY24 (period ends Sep 30, 2024).
Item	Value	Share of revenue	Year over year
Revenue	2.49	100%	+8%
Diagnostic information	2.43	98%	+9%
All other	0.06	2%	−9%
Cost of revenue	−1.68	67%
Gross profit	0.81	33% margin	+0pp
SG&A	−0.45	18%	+1pp
Other	−0.03	1%	+0pp
Operating profit	0.33	13% margin	−2pp
Interest & other costs	−0.04
Tax	−0.07
Net profit	0.23	9% margin	−1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q3 FY26 Jul 1 – Sep 30, 2026 reported Oct 23, 2026 Operating margin 15% Net profit $0.31B	Jul 1 – Sep 30, 2026	Oct 23, 2026	$3.10B	+10%	15%	$0.31B	10%
Q2 FY26 Apr 1 – Jun 30, 2026 reported Jul 23, 2026 Operating margin 15% Net profit $0.32B	Apr 1 – Jun 30, 2026	Jul 23, 2026	$3.04B	+10%	15%	$0.32B	11%
Q1 FY26 Jan 1 – Mar 31, 2026 reported Apr 22, 2026 Operating margin 14% Net profit $0.25B	Jan 1 – Mar 31, 2026	Apr 22, 2026	$2.90B	+9%	14%	$0.25B	9%
Q4 FY25 Oct 1 – Dec 31, 2025 reported Feb 26, 2026 Operating margin 14% Net profit $0.25B	Oct 1 – Dec 31, 2025	Feb 26, 2026	$2.81B	+7%	14%	$0.25B	9%
Q3 FY25 Jul 1 – Sep 30, 2025 reported Oct 21, 2025 Operating margin 14% Net profit $0.25B	Jul 1 – Sep 30, 2025	Oct 21, 2025	$2.82B	+13%	14%	$0.25B	9%
Q3 FY24 Jul 1 – Sep 30, 2024 reported Oct 23, 2024 Operating margin 13% Net profit $0.23B	Jul 1 – Sep 30, 2024	Oct 23, 2024	$2.49B	+8%	13%	$0.23B	9%